I.V. EDTA chelation or Oral EDTA chelation?
I.V. therapy has a direct and powerful effect on the body almost instantaneously. An I.V. session usually lasts about 3 to 4 hours, during which about 1500 mg to 3000 mg of EDTA (plus vitamin C and other nutrients) are administered. The number of treatments necessary (generally about 20-50 sessions) depends on the individual's condition. Candidates for I.V. chelation are people that have been diagnosed with serious atherosclerosis, heavy metal poisoning, or symptoms of vascular occlusion or significant calcification of tissues.
5% to 10% of an oral dose of EDTA is absorbed, compared with 100% of an
I.V. dose. Therefore, the time and dosage required to achieve the same
benefits with the oral form are quite different. What can be achieved
in only a few hours with I.V. EDTA chelation may take several weeks or
months with oral EDTA chelation. However, oral EDTA may be appropriate
for people whose condition does not demand rapid action. For example,
oral chelation can be used to:
Oral EDTA is not meant to replace I.V. therapy for those people who have serious vascular disease. It is very useful, though, for people who have completed an I.V. course and want to stay on a maintenance program, for people who "for whatever reason" are unable or unwilling to undergo I.V. chelation, and for those whose I.V. treatments may have been interrupted.
The Politics of EDTA Chelation
Organizations like the American Heart Association and the American Medical Association, which condemn EDTA chelation as ineffective for treating vascular disease, often quote the Danish and New Zealand studies, mentioned earlier, to support their position. What they fail to mention is that the Danish studies were criticized by the Danish Committee for Investigation into Scientific Dishonesty because of improper randomization and double-blinding, as well as premature breaking of the blinding code, which amounted to a deliberate bias. When the results of the New Zealand study were examined by 2 independent statisticians, it was concluded that the trial actually supported the efficacy of EDTA.
You can find out more about how public relations firms shape and manipulate the public's beliefs on the "Why you believe what you believe" page.
"Virtually every study that has looked at the efficacy of EDTA chelation in vascular disease has demonstrated significant improvements."
It is unlikely that any other issue in modern medicine has been more highly politicized than that of EDTA chelation therapy, and it is clear that most of the opposition to EDTA is due to the threat this therapy represents, not to patients' health but to the bank balances of orthodox physicians, pharmaceutical companies, and hospitals. Treating cardiovascular diseases is big business in the United States (and the rest of the Western world), bringing in tens of billions of dollars each year.
Each coronary bypass surgery procedure costs between $25,000 and $50,000. Each angioplasty costs about $15,000. Drugs for reducing cholesterol, lowering high blood pressure, and normalizing heart rhythm bring the pharmaceutical industry hundreds of millions of dollars each year. And these are just the most common examples. What happens when you add EDTA chelation therapy to this mix?
A course of I.V. EDTA chelation therapy costs between $2000 and $4000, oral EDTA is even less costly. To the degree that these therapies reduce the need for the more expensive conventional therapies - a large degree, indeed - they threaten to diminish the income of a significant portion of the medical establishment. Consider this one example: as noted earlier, in a study of 65 patients who were treated with I.V. EDTA while they were waiting for coronary bypass surgery surgery, 58 (89%) no longer required the procedure. At $50,000 per procedure not done, that means that surgeons and hospitals gave up nearly $3 million just for these few patients. Now remember, that coronary bypass surgery is the most common surgical procedure performed in the US (368,000 in 1989).
Edta Chelation And The Medical Profession
Given these figures, it's not hard to understand why the medical profession is so in love with coronary bypass surgery and related procedures. As one physician noted, "It pays the bills." So enamored are they of these procedures that they perform them even when they are not necessary. In an article published in no less prestigious a publication than the "Journal of the American Medical Association", the authors concluded that only 56% of the surgeries performed were for appropriate reasons, 30% for equivocal reasons, and 14% for inappropriate reasons.
The percentage of appropriate surgeries varied from 37% in some hospitals to 78% in others. When you consider that even when it is "appropriate," coronary bypass surgery surgery is no better than conventional medical treatments for improving survival, you have to wonder whether the real "miracle" of heart surgery does not entail bringing people back from death's door, as much as turning a common chronic degenerative disease into a source of outrageous fortune. If you needed one example of why the cost of health care - disease care, really - has gone into earth orbit, you need look no further than the conventional treatment of heart disease. Health spending in the U.S. is examined in more detail here.
More about coronary bypass surgery and the politics of heart disease here.
Given these figures, it's also not very hard to understand why the medical profession has reacted so violently against physicians who practice chelation therapy, often attempting to put them out of business. Because EDTA has long been approved for treating heavy metal poisoning, and because physicians are free to use any "approved" medication for any use they see fit, as long it does not endanger the patient, EDTA chelation therapy is perfectly legal. This has not stopped medical boards in a number of states from bringing charges against physicians who prescribe EDTA chelation for vascular disease, smearing them as "quacks," and attempting to restrict the use of this therapy. Fortunately, most of these attempts have failed.
You can be certain that if EDTA had a large pharmaceutical company advocating its use, these problems would quickly evaporate. But since the patent for EDTA ran out nearly 30 years ago, there are no huge profits to be made from marketing it. With no pot of gold at the end of the EDTA rainbow, no one is going to put up the hundreds of millions of dollars required to do the randomized, double-blind, placebo-controlled clinical trials required to get the FDA to approve EDTA for vascular disease. And with few large, randomized, double-blind, placebo-controlled clinical trials to refer to, the conventional medical establishment feels justified in condemning EDTA therapy as "unproven." It's a familiar "Catch 22" that faces all natural or unpatentable therapies.
Dr. Garry Gordon - The Father Of EDTA Chelation Therapy
Because EDTA removes heavy metals from the body, it is important to supplement your diet with a good multi-mineral supplement while taking EDTA, to avoid any mineral deficiency, especially in zinc. I recommend you supplement your diet with a multi-vitamin/mineral supplement, as well as a calcium-magnesium-zinc supplement.